TRYDIC PLUS by Chemisis Pharmaceuticals contains Trypsin and Chymotrypsin, which are proteolytic enzymes used primarily to reduce inflammation and edema associated with various conditions. These enzymes help in the digestion of proteins and have anti-inflammatory, anti-edematous, and fibrinolytic properties, making them useful in treating conditions such as postoperative swelling, sports injuries, and chronic inflammatory diseases.

• Trypsin and Chymotrypsin: These are naturally occurring enzymes that help break down proteins into smaller peptides. In a therapeutic setting, they reduce inflammation and promote healing by breaking down inflammatory proteins at the site of injury.

The typical dosage of TRYDIC PLUS is one to two tablets taken two to three times daily, preferably on an empty stomach or as directed by a healthcare provider. This helps ensure maximum absorption and effectiveness of the enzymes. Common side effects may include mild gastrointestinal disturbances such as nausea, diarrhea, and abdominal discomfort. Allergic reactions are rare but can occur, manifesting as rash, itching, swelling, or difficulty breathing. Patients should inform their healthcare provider of any known allergies or pre-existing conditions before starting treatment with TRYDIC PLUS.